Join us for this free educational webinar, being delivered in partnership RCPath Corporate Member, PathQA, and find out about end to end quality assurance in digital pathology.
As digital pathology momentum continues to grow it has never been more important to measure, report, track and, where possible, correct sources of variable quality across the whole modern workflow, in order to easier facilitate and consistently validate digital adoption. The safety and scalability of the lab of the future, including use of trustworthy AI and imaging technology, is reliant on the robustness of quality and interconnectivity standards in the labs of today. This webinar will explore current methodologies with the potential for creating end-to-end, vendor-agnostic QA environments based on interoperable solutions and standards to support establishing and scaling digital pathology deployments.
Speakers
Rick Salmon
Rick Salmon has a PhD in biophysics with publications in protein biochemistry, cell biology, and digital pathology colour standardisation for AI. He holds an Innovate UK FLF Fellowship researching QA methodologies for pathology and AI diagnostic efficacy from validated data. As CEO at PathQA, Rick's focus is on technology partnerships, growth strategy and industry leadership on the topic of digital QA.
John Groth MD
John Groth, M.D., is a pathologist at Endeavor Health, in Illinois, USA, where he is currently a physician informaticist, leading the transition to digital pathology for primary clinical work, using an enterprise imaging strategy. He currently is the co-chair for the Digital Pathology Association's Regulatory & Standards Task Force, member of the College of American Pathologists Digital & Computational Pathology Committee, member of the American Society of Clinical Pathology's Patient Champions Committee, member of the Endeavor Health Digital Health Committee, vice president of the Illinois Society of Cytotechnology, and treasurer of the Chicago Pathology Society.
Sofiane Azdad MD
Soufiane Zakaria Azdad, MD, is a practicing anatomical pathologist and the CEO and co-founder of Algoscope, an ISO 13485 certified company. A graduate of EDHEC Business School with a University Diploma in Quality Assurance from Paris Descartes University, he built Algoscope around a single clinical observation: that the pre-analytical phase, from surgical extraction to slide preparation, remains the most error-prone and least standardized part of the pathology workflow.
Algoscope's platform is CE-marked (IVDR 2017/746) since January 2026 and is currently deployed in pathology laboratories in France, Belgium, and the United Kingdom.
